A citation-based method for searching scientific literature

Angela R Bradbury, Brian L Egleston, Linda J Patrick-Miller, Neil Rustgi, Amanda Brandt, Jamie Brower, Laura DiGiovanni, Dominique Fetzer, Christopher Berkelbach, Jessica M Long, Jacquelyn Powers, Jill E Stopfer, Susan M Domchek. Clin Genet 2020
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
David Cella, Chanita Hughes, Amy Peterman, Chih-Hung Chang, Beth N Peshkin, Marc D Schwartz, Lari Wenzel, Amy Lemke, Alfred C Marcus, Caryn Lerman. Health Psychol 2002
166
100

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
67
100

Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma.
Amelia K Smit, Ainsley J Newson, Megan Best, Caro-Anne Badcock, Phyllis N Butow, Judy Kirk, Kate Dunlop, Georgina Fenton, Anne E Cust. Eur J Hum Genet 2018
13
50

Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Anne Brédart, Jean-Luc Kop, Julia Dick, Alejandra Cano, Antoine De Pauw, Amélie Anota, Joan Brunet, Peter Devilee, Dominique Stoppa-Lyonnet, Rita Schmutzler,[...]. BMJ Open 2019
2
50

Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis.
Brandie Heald, Heather Hampel, James Church, Beth Dudley, Michael J Hall, Maureen E Mork, Aparajita Singh, Elena Stoffel, Jessica Stoll, Y Nancy You,[...]. Fam Cancer 2020
6
50

Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort.
Charité Ricker, Julie O Culver, Katrina Lowstuter, Duveen Sturgeon, Julia D Sturgeon, Christopher R Chanock, William J Gauderman, Kevin J McDonnell, Gregory E Idos, Stephen B Gruber. Cancer Genet 2016
43
50

Association of Germline Genetic Test Type and Results With Patient Cancer Worry After Diagnosis of Breast Cancer.
Steven J Katz, Kevin C Ward, Ann S Hamilton, Paul Abrahamse, Sarah T Hawley, Allison W Kurian. JCO Precis Oncol 2018
4
50

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
50

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
Mary B Daly, Robert Pilarski, Jennifer E Axilbund, Michael Berry, Saundra S Buys, Beth Crawford, Meagan Farmer, Susan Friedman, Judy E Garber, Seema Khan,[...]. J Natl Compr Canc Netw 2016
111
50

Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Heidi S Lumish, Hallie Steinfeld, Carrie Koval, Donna Russo, Elana Levinson, Julia Wynn, James Duong, Wendy K Chung. J Genet Couns 2017
61
50

Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
Valentina Vysotskaia, K Eerik Kaseniit, Leslie Bucheit, Kaylene Ready, Kristin Price, Katherine Johansen Taber. Cancer 2020
7
50

Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics.
Jada G Hamilton, Mark E Robson. Hastings Cent Rep 2019
7
50

Patient experiences with gene panels based on exome sequencing in clinical diagnostics: high acceptance and low distress.
A S Sie, J B Prins, W A G van Zelst-Stams, J A Veltman, I Feenstra, N Hoogerbrugge. Clin Genet 2015
16
50

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
44
50

Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
I Esteban, M Vilaró, E Adrover, A Angulo, E Carrasco, N Gadea, A Sánchez, T Ocaña, G Llort, R Jover,[...]. Psychooncology 2018
17
50

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
197
50

Psychological distress related to BRCA testing in ovarian cancer patients.
Merete Bjørnslett, Alv A Dahl, Øystein Sørebø, Anne Dørum. Fam Cancer 2015
16
50



NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
93
50


A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Li Sun, Adam Brentnall, Shreeya Patel, Diana S M Buist, Erin J A Bowles, D Gareth R Evans, Diana Eccles, John Hopper, Shuai Li, Melissa Southey,[...]. JAMA Oncol 2019
31
50

Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Julie O Culver, Charité N Ricker, Joseph Bonner, John Kidd, Duveen Sturgeon, Rachel Hodan, Kerry Kingham, Katrina Lowstuter, Nicolette M Chun, Alexandra P Lebensohn,[...]. Cancer 2021
2
50

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
Susan M Domchek, Angela Bradbury, Judy E Garber, Kenneth Offit, Mark E Robson. J Clin Oncol 2013
156
50

Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing.
Angela R Bradbury, Linda J Patrick-Miller, Brian L Egleston, Laura DiGiovanni, Jamie Brower, Diana Harris, Evelyn M Stevens, Kara N Maxwell, Abha Kulkarni, Tyler Chavez,[...]. Genet Med 2016
40
50

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
Samir Gupta, Dawn Provenzale, Scott E Regenbogen, Heather Hampel, Thomas P Slavin, Michael J Hall, Xavier Llor, Daniel C Chung, Dennis J Ahnen, Travis Bray,[...]. J Natl Compr Canc Netw 2017
70
50

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.
Eric R Manahan, Henry M Kuerer, Molly Sebastian, Kevin S Hughes, Judy C Boughey, David M Euhus, Susan K Boolbol, Walton A Taylor. Ann Surg Oncol 2019
52
50



Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study.
Angela Bradbury, Linda Patrick-Miller, Diana Harris, Evelyn Stevens, Brian Egleston, Kyle Smith, Rebecca Mueller, Amanda Brandt, Jill Stopfer, Shea Rauch,[...]. J Med Internet Res 2016
40
50

Longitudinal follow-up after telephone disclosure in the randomized COGENT study.
Madison K Kilbride, Brian L Egleston, Michael J Hall, Linda J Patrick-Miller, Mary B Daly, Pamela Ganschow, Generosa Grana, Olufunmilayo I Olopade, Dominique Fetzer, Amanda Brandt,[...]. Genet Med 2020
1
100

Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Alyssa Kne, Heather Zierhut, Shari Baldinger, Karen K Swenson, Pamela Mink, Patricia McCarthy Veach, Michaela L Tsai. J Genet Couns 2017
16
50

Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode.
Laurie E Steffen, Ruofei Du, Amanda Gammon, Jeanne S Mandelblatt, Wendy K Kohlmann, Ji-Hyun Lee, Saundra S Buys, Antoinette M Stroup, Rebecca A Campo, Kristina G Flores,[...]. Cancer Epidemiol Biomarkers Prev 2017
10
50

Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
Kimberly Kelly, Howard Leventhal, Monica Marvin, Deborah Toppmeyer, Jill Baran, Marvin Schwalb. Cancer Control 2004
28
50

Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility.
Angela R Bradbury, Linda Patrick-Miller, Jessica Long, Jacquelyn Powers, Jill Stopfer, Andrea Forman, Christina Rybak, Kristin Mattie, Amanda Brandt, Rachelle Chambers,[...]. Genet Med 2015
52
50

Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Morgan Butrick, Scott Kelly, Beth N Peshkin, George Luta, Rachel Nusbaum, Gillian W Hooker, Kristi Graves, Lisa Feeley, Claudine Isaacs, Heiddis B Valdimarsdottir,[...]. Genet Med 2015
58
50

Implementing and Optimizing Inpatient Access to Dermatology Consultations via Telemedicine: An Experiential Study.
Kartik Dhaduk, Daniel Miller, Alan Schliftman, Ammar Athar, Zohair Ahmed Al Aseri, Alison Echevarria, Brian Hale, Corey Scurlock, Christian Becker. Telemed J E Health 2021
6
50

Clinical models of telehealth in genetics: A regional telegenetics landscape.
Alissa B Terry, Amanda Wylie, Melissa Raspa, Beth Vogel, Kunal Sanghavi, Luba Djurdjinovic, Michele Caggana, Joann Bodurtha. J Genet Couns 2019
19
50



Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
50

The Empirical Evidence for Telemedicine Interventions in Mental Disorders.
Rashid L Bashshur, Gary W Shannon, Noura Bashshur, Peter M Yellowlees. Telemed J E Health 2016
108
50

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
50

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
Adam H Buchanan, Santanu K Datta, Celette Sugg Skinner, Gail P Hollowell, Henry F Beresford, Thomas Freeland, Benjamin Rogers, John Boling, P Kelly Marcom, Martha B Adams. J Genet Couns 2015
78
50


Examination of the Patient-Focused Impact of Cancer Telegenetics Among a Rural Population: Comparison with Traditional In-Person Services.
Nan M Solomons, Amanda E Lamb, Frances L Lucas, Eileen F McDonald, Susan Miesfeldt. Telemed J E Health 2018
20
50

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: attributes, cancer worry, and barriers to testing in a multicenter clinical cohort.
C Foster, D G R Evans, R Eeles, D Eccles, S Ashley, L Brooks, T Cole, J Cook, R Davidson, H Gregory,[...]. Genet Test 2004
48
50


Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
148
50

Patients' understanding of and responses to multiplex genetic susceptibility test results.
Kimberly A Kaphingst, Colleen M McBride, Christopher Wade, Sharon Hensley Alford, Robert Reid, Eric Larson, Andreas D Baxevanis, Lawrence C Brody. Genet Med 2012
84
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.